When she got home, she threw up and collapsed into bed, falling asleep around 5 p.m. The following morning, she went to urgent care, where doctors took an X-ray of her chest. It was the same day they ...

Azercabtagene zapreleucel has been granted fast track designation from the FDA for the treatment of diffuse large B-cell ...

The following is a summary of “Favorable correlation between neutrophil percentages obtained using automated hematology ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi® (tafasitamab) by its Mexican affiliate, ...

More than 700 oncologists, cancer researchers and advocates will converge on the Crescent City this week as part of the 2025 NeauxCancer Conference. The event got its start four years ago by the ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

Each year, high school students can nominate one another to organize teams that compete to raise money over a seven-week ...

Amid the near daily announcement of new initiatives, two documents stand out in the Trump deregulatory agenda: the Unleashing ...

We can’t change Miracle’s diagnosis,” Jessica Mendezona, director of operations. “But we can change the way her story ends — ...

Avantax Advisory Services Inc. acquired a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,140 ...

The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...

Affimed (NASDAQ:AFMD – Get Free Report) is expected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.91) per ...